SCHEMBL7988231

SCHEMBL7988231

COc1ccc(Cn2cnc(NC(=O)c3ccccc3)c2C(N)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ADORA3 P0DMS8 6/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC2 Q92769 2/20 0.45
HDAC3 O15379 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TMIGD3 P0DMS9 2/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
ADORA1 P30542 1/20 0.44
KCNK9 Q9NPC2 1/20 0.44
CDKN1A P38936 1/20 0.43
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974029 0.96 ADORA3 (0.50) NPC1RAB9AADORA3HDAC1HDAC6
SCHEMBL7975241 0.89 GAA (0.50) NPC1RAB9AADORA3HDAC1HDAC6
SCHEMBL7985340 0.89 NTRK1 (0.51) NPC1RAB9AADORA3KMT2AKCNK9
SCHEMBL7984937 0.89 ADORA3 (0.52) NPC1RAB9AADORA3KMT2ACDK5
SCHEMBL7974265 0.88 MCHR1 (0.47) NPC1RAB9AADORA3HDAC1HDAC2
SCHEMBL7974581 0.87 LMNA (0.51) NPC1RAB9AADORA3HDAC1HDAC6
SCHEMBL7984694 0.86 NR1H4 (0.53) NPC1RAB9AHDAC1HDAC6HDAC2
SCHEMBL7973841 0.86 RAB9A (0.47) NPC1RAB9AHDAC1HDAC6HDAC2
SCHEMBL7984668 0.84 POLB (0.49) NPC1RAB9AADORA3MMP13
SCHEMBL7973996 0.83 POLB (0.49) NPC1RAB9AADORA3HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed